Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$5.19M
14 trades · 4 insiders
Net · 90d
$-5.19M
Insiders on file
22
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| GREEN ANDREW M | VP Regulatory | 44 | $0 | $2.48M | 2026-09-10 |
| Mackin James P | President & CEO | 82 | $0 | $20.88M | 2026-08-19 |
| Berry Lance A | Executive VP, CFO | 15 | $0 | $1.03M | 2026-08-14 |
| Holloway Jean F | SVP, General Counsel | 91 | $0 | $6.34M | 2026-08-12 |
| SEMEDO ANTHONY B. | Director | 12 | $53.1K | $390.7K | 2026-06-02 |
| Hoff Elizabeth A | Director | 6 | $0 | $189.4K | 2026-05-18 |
| Borgstrom Marna P | Director | 6 | $0 | $0 | 2026-05-18 |
| Salveson Jon W | Director | 5 | $0 | $0 | 2026-05-18 |
| Burbank Jeffrey H | Director | 5 | $0 | $0 | 2026-05-18 |
| BEVEVINO DANIEL J | Director | 5 | $0 | $0 | 2026-05-18 |
| Bullock James | Director | 5 | $0 | $0 | 2026-05-18 |
| ACKERMAN THOMAS F | Director | 5 | $0 | $0 | 2026-05-18 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | 68 | $0 | $6.17M | 2026-03-03 |
| Davis John E | Senior VP, Global Sales | 70 | $0 | $3.39M | 2026-03-03 |
| Horton Amy | VP, Chief Accounting Officer | 78 | $0 | $2.69M | 2026-03-03 |
| Getz Matthew A | VP, Human Resources | 39 | $0 | $650.0K | 2024-08-16 |
| Maney Rochelle L. | VP, Quality | 35 | $0 | $351.0K | 2024-03-05 |
| Tyrs Florian | VP, Global Operations | 6 | $0 | $29.5K | 2024-02-27 |
| THOMSON ROBERT C | VP Research & Development | 3 | $0 | $0 | 2024-02-23 |
| Maier Dennis B | Vice President, Operations | 27 | $0 | $417.9K | 2023-06-06 |
| LEE DAVID ASHLEY | Executive VP, COO & CFO | 23 | $0 | $480.5K | 2023-03-02 |
| Barthold Franz Peter | VP, Research & Development | 12 | $0 | $0 | 2022-11-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-09-10 | 2026-09-11 | 11,480 | $24.97 | $286.7K | 40,160 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-09-10 | 2026-09-11 | 11,480 | $24.97 | $286.7K | 40,160 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-09-03 | 2026-09-04 | 1,493 | $26.02 | $38.8K | 51,640 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-09-03 | 2026-09-04 | 1,493 | $26.02 | $38.8K | 51,640 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-09-02 | 2026-09-04 | 6,510 | $27.27 | $177.5K | 53,133 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-09-02 | 2026-09-04 | 6,510 | $27.27 | $177.5K | 53,133 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2026-08-19 | 2026-08-20 | 70,000 | $28.96 | $2.03M | 877,275 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2026-08-19 | 2026-08-20 | 70,000 | $28.95 | $2.03M | 877,275 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 2026-08-14 | 2026-08-17 | 715 | $28.55 | $20.4K | 210,112 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-08-14 | 2026-08-17 | 616 | $28.55 | $17.6K | 59,643 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-08-14 | 2026-08-17 | 616 | $28.55 | $17.6K | 59,643 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 2026-08-14 | 2026-08-17 | 715 | $28.55 | $20.4K | 210,112 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2026-08-12 | 2026-08-12 | 977 | $28.49 | $27.8K | 184,118 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2026-08-12 | 2026-08-12 | 977 | $28.49 | $27.8K | 184,118 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise deriv | 2026-06-11 | 2026-06-15 | 30,000 | — | $0 | 0 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise deriv | 2026-06-11 | 2026-06-15 | 14,001 | — | $0 | 0 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise | 2026-06-11 | 2026-06-15 | 30,000 | $11.03 | $330.9K | 90,259 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-06-11 | 2026-06-15 | 14,001 | $20.71 | $290.0K | 60,259 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | M Exercise | 2026-06-11 | 2026-06-15 | 14,001 | $18.44 | $258.2K | 74,260 | SEC↗ |
| GREEN ANDREW M | SVP, Regulatory and Quality | S Sale | 2026-06-11 | 2026-06-15 | 30,000 | $20.69 | $620.7K | 60,259 | SEC↗ |
| SEMEDO ANTHONY B. | Director | J Other | 2026-06-02 | 2026-06-04 | 6,325 | — | $0 | 6,325 | SEC↗ |
| SEMEDO ANTHONY B. | Director | J Other | 2026-06-02 | 2026-06-04 | 6,325 | — | $0 | 40,635 | SEC↗ |
| ACKERMAN THOMAS F | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 157,472 | SEC↗ |
| BEVEVINO DANIEL J | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 157,637 | SEC↗ |
| Bullock James | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 76,223 | SEC↗ |
| Burbank Jeffrey H | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 61,372 | SEC↗ |
| Hoff Elizabeth A | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 34,765 | SEC↗ |
| Salveson Jon W | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 137,416 | SEC↗ |
| SEMEDO ANTHONY B. | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 46,960 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2026-05-18 | 2026-05-20 | 7,576 | — | $0 | 56,664 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2026-05-14 | 2026-05-19 | 7,850 | — | $0 | 56,938 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2026-03-04 | 2026-03-04 | 8,962 | $38.00 | $340.6K | 185,095 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2026-03-03 | 2026-03-04 | 17,887 | $37.78 | $675.8K | 947,275 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 2026-03-03 | 2026-03-04 | 6,316 | $37.78 | $238.6K | 210,827 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2026-03-03 | 2026-03-04 | 4,573 | $37.78 | $172.8K | 230,794 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2026-03-03 | 2026-03-04 | 2,149 | $37.78 | $81.2K | 60,097 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2026-03-03 | 2026-03-04 | 3,843 | $37.78 | $145.2K | 194,057 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2026-03-03 | 2026-03-04 | 901 | $37.78 | $34.0K | 139,088 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2026-03-02 | 2026-03-03 | 2,784 | $38.02 | $105.8K | 206,522 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 2026-03-02 | 2026-03-03 | 5,178 | $38.02 | $196.9K | 176,269 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2026-03-02 | 2026-03-03 | 2,183 | $38.02 | $83.0K | 170,105 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2026-03-02 | 2026-03-03 | 14,911 | $38.02 | $566.9K | 848,214 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2026-03-02 | 2026-03-03 | 1,513 | $38.02 | $57.5K | 40,408 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2026-03-02 | 2026-03-03 | 641 | $38.02 | $24.4K | 132,514 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2026-03-02 | 2026-03-04 | 116,948 | — | $0 | 965,162 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | A Award | 2026-03-02 | 2026-03-04 | 40,874 | — | $0 | 217,143 | SEC↗ |
| Davis John E | Chief Commercial Officer | A Award | 2026-03-02 | 2026-03-04 | 28,845 | — | $0 | 235,367 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | A Award | 2026-03-02 | 2026-03-04 | 21,838 | — | $0 | 62,246 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | A Award | 2026-03-02 | 2026-03-04 | 27,795 | — | $0 | 197,900 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2026-03-02 | 2026-03-04 | 7,475 | — | $0 | 139,989 | SEC↗ |
| Davis John E | Chief Commercial Officer | A Award | 2026-02-24 | 2026-02-25 | 20,438 | — | $0 | 209,306 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2026-02-24 | 2026-02-25 | 2,075 | $35.69 | $74.1K | 188,868 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | A Award | 2026-02-24 | 2026-02-25 | 37,482 | — | $0 | 181,447 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 2026-02-24 | 2026-02-25 | 4,485 | $35.69 | $160.1K | 143,965 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2026-02-24 | 2026-02-25 | 13,936 | $35.69 | $497.4K | 766,095 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2026-02-24 | 2026-02-25 | 97,030 | — | $0 | 863,125 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2026-02-24 | 2026-02-25 | 1,668 | $35.69 | $59.5K | 152,203 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | A Award | 2026-02-24 | 2026-02-25 | 20,085 | — | $0 | 172,288 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2026-02-24 | 2026-02-25 | 1,259 | $35.69 | $44.9K | 41,921 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2026-02-24 | 2026-02-25 | 5,658 | — | $0 | 133,155 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2026-02-24 | 2026-02-25 | 830 | $35.69 | $29.6K | 127,497 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2026-02-23 | 2026-02-25 | 3,773 | $37.59 | $141.8K | 190,943 | SEC↗ |
| Berry Lance A | EVP, COO, CFO & Treasurer | S Sale | 2026-02-23 | 2026-02-25 | 4,981 | $37.59 | $187.2K | 148,450 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2026-02-23 | 2026-02-25 | 20,962 | $37.59 | $788.0K | 780,031 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2026-02-23 | 2026-02-25 | 3,079 | $37.59 | $115.7K | 153,871 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2026-02-23 | 2026-02-25 | 2,423 | $37.59 | $91.1K | 43,180 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2026-02-23 | 2026-02-25 | 1,731 | $37.59 | $65.1K | 128,327 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-12-15 | 2025-12-17 | 5,000 | $45.11 | $225.6K | 193,842 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-12-08 | 2025-12-09 | 4,572 | $44.42 | $203.1K | 130,058 | SEC↗ |
| Mackin James P | President & CEO | M Exercise deriv | 2025-12-03 | 2025-12-04 | 30,921 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-12-03 | 2025-12-04 | 5,267 | $45.30 | $238.6K | 156,093 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-12-03 | 2025-12-04 | 2,048 | $45.30 | $92.8K | 161,360 | SEC↗ |
| Mackin James P | President & CEO | M Exercise | 2025-12-03 | 2025-12-04 | 30,921 | $29.62 | $915.9K | 831,914 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-12-03 | 2025-12-04 | 30,921 | $45.46 | $1.41M | 800,993 | SEC↗ |
| Mackin James P | President & CEO | M Exercise deriv | 2025-12-02 | 2025-12-03 | 30,921 | — | $0 | 0 | SEC↗ |
| Mackin James P | President & CEO | M Exercise | 2025-12-02 | 2025-12-03 | 30,921 | $29.62 | $915.9K | 831,914 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-12-02 | 2025-12-03 | 30,921 | $45.56 | $1.41M | 800,993 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | G Gift | 2025-12-01 | 2025-12-02 | 750 | — | $0 | 134,630 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise deriv | 2025-11-21 | 2025-11-24 | 27,075 | — | $0 | 0 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise deriv | 2025-11-21 | 2025-11-24 | 20,301 | — | $0 | 0 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise | 2025-11-21 | 2025-11-24 | 27,075 | $11.03 | $298.6K | 71,828 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-21 | 2025-11-24 | 5,715 | $45.35 | $259.2K | 44,753 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-21 | 2025-11-24 | 14,586 | $44.92 | $655.2K | 50,468 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise | 2025-11-21 | 2025-11-24 | 20,301 | $18.44 | $374.4K | 65,054 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-21 | 2025-11-24 | 8,370 | $45.35 | $379.6K | 44,753 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-21 | 2025-11-24 | 18,705 | $44.91 | $840.0K | 53,123 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise deriv | 2025-11-20 | 2025-11-24 | 2,033 | — | $0 | 20,301 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise deriv | 2025-11-20 | 2025-11-24 | 1,355 | — | $0 | 27,075 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-20 | 2025-11-24 | 11,888 | $44.14 | $524.7K | 44,753 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise | 2025-11-20 | 2025-11-24 | 2,033 | $18.44 | $37.5K | 46,786 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-20 | 2025-11-24 | 2,033 | $44.32 | $90.1K | 44,753 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-20 | 2025-11-24 | 1,355 | $44.28 | $60.0K | 44,753 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise | 2025-11-20 | 2025-11-24 | 1,355 | $11.03 | $14.9K | 46,108 | SEC↗ |
| Hoff Elizabeth A | Director | S Sale | 2025-11-18 | 2025-11-19 | 4,200 | $45.10 | $189.4K | 27,189 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise deriv | 2025-11-17 | 2025-11-18 | 6,394 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2025-11-17 | 2025-11-18 | 6,394 | — | $0 | 0 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-11-17 | 2025-11-18 | 6,000 | $45.73 | $274.4K | 135,380 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise | 2025-11-17 | 2025-11-18 | 6,394 | $29.62 | $189.4K | 205,236 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-11-17 | 2025-11-18 | 6,394 | $45.17 | $288.8K | 198,842 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-11-17 | 2025-11-18 | 6,394 | $45.17 | $288.8K | 163,408 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2025-11-17 | 2025-11-18 | 6,394 | $29.62 | $189.4K | 169,802 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise deriv | 2025-11-14 | 2025-11-18 | 6,393 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2025-11-14 | 2025-11-18 | 6,393 | — | $0 | 0 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise | 2025-11-14 | 2025-11-18 | 6,393 | $29.62 | $189.4K | 205,235 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-11-14 | 2025-11-18 | 6,393 | $44.67 | $285.6K | 198,842 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-11-14 | 2025-11-18 | 6,393 | $45.00 | $287.7K | 163,408 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2025-11-14 | 2025-11-18 | 6,393 | $29.62 | $189.4K | 169,801 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-13 | 2025-11-14 | 4,993 | $45.86 | $229.0K | 56,641 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-11-13 | 2025-11-14 | 5,761 | $45.86 | $264.2K | 163,408 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-11-13 | 2025-11-14 | 34,210 | $45.86 | $1.57M | 800,993 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-11-13 | 2025-11-14 | 6,563 | $45.86 | $301.0K | 198,842 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-11-13 | 2025-11-14 | 3,482 | $45.86 | $159.7K | 141,380 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2025-11-11 | 2025-11-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2025-11-11 | 2025-11-12 | 10,000 | $11.03 | $110.3K | 179,169 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-11-11 | 2025-11-12 | 10,000 | $46.18 | $461.8K | 169,169 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-11-10 | 2025-11-12 | 2,566 | $44.62 | $114.5K | 61,634 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-11-10 | 2025-11-12 | 1,789 | $44.62 | $79.8K | 144,862 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-11-10 | 2025-11-12 | 3,373 | $44.62 | $150.5K | 205,405 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-11-10 | 2025-11-12 | 17,580 | $44.62 | $784.4K | 835,203 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-11-10 | 2025-11-12 | 2,960 | $44.62 | $132.1K | 169,169 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise deriv | 2025-08-27 | 2025-08-28 | 18,200 | — | $0 | 0 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-08-27 | 2025-08-28 | 18,200 | $44.02 | $801.2K | 64,200 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | M Exercise | 2025-08-27 | 2025-08-28 | 18,200 | $11.03 | $200.7K | 82,400 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2025-08-25 | 2025-08-26 | 10,000 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-08-25 | 2025-08-26 | 10,000 | $44.37 | $443.7K | 172,129 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2025-08-25 | 2025-08-26 | 10,000 | $11.03 | $110.3K | 182,129 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-08-15 | 2025-08-19 | 12,500 | $42.32 | $529.0K | 852,783 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise deriv | 2025-08-12 | 2025-08-14 | 10,802 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2025-08-12 | 2025-08-14 | 16,975 | — | $0 | 0 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise | 2025-08-12 | 2025-08-14 | 10,802 | $26.24 | $283.4K | 219,580 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-08-12 | 2025-08-14 | 10,802 | $43.67 | $471.7K | 208,778 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-08-12 | 2025-08-14 | 16,975 | $43.01 | $730.1K | 178,510 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-08-12 | 2025-08-14 | 6,381 | $43.02 | $274.5K | 172,129 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2025-08-12 | 2025-08-14 | 16,975 | $26.24 | $445.4K | 195,485 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise deriv | 2025-08-08 | 2025-08-11 | 7,992 | — | $0 | 0 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise | 2025-08-08 | 2025-08-11 | 7,992 | $29.62 | $236.7K | 154,643 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-08-08 | 2025-08-11 | 7,992 | $38.49 | $307.6K | 146,651 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-06-17 | 2025-06-18 | 1,236 | $29.50 | $36.5K | 64,200 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-06-17 | 2025-06-18 | 13,764 | $29.50 | $406.0K | 65,436 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-06-13 | 2025-06-16 | 1,826 | $28.43 | $51.9K | 79,200 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-06-13 | 2025-06-16 | 14,306 | $28.42 | $406.6K | 81,026 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-06-13 | 2025-06-16 | 1,253 | $28.47 | $35.7K | 95,332 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-06-13 | 2025-06-16 | 8,747 | $28.46 | $248.9K | 96,585 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-05-27 | 2025-05-27 | 8,748 | $29.00 | $253.7K | 178,510 | SEC↗ |
| SEMEDO ANTHONY B. | Director | S Sale | 2025-05-23 | 2025-05-27 | 2,600 | $28.47 | $74.0K | 33,059 | SEC↗ |
| SEMEDO ANTHONY B. | Director | S Sale | 2025-05-23 | 2025-05-27 | 2,600 | $28.47 | $74.0K | 39,384 | SEC↗ |
| Bullock James | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 68,647 | SEC↗ |
| Burbank Jeffrey H | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 53,796 | SEC↗ |
| Hoff Elizabeth A | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 31,389 | SEC↗ |
| Salveson Jon W | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 129,840 | SEC↗ |
| ACKERMAN THOMAS F | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 149,896 | SEC↗ |
| BEVEVINO DANIEL J | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 150,061 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 49,088 | SEC↗ |
| SEMEDO ANTHONY B. | Director | A Award | 2025-05-22 | 2025-05-27 | 6,325 | — | $0 | 41,984 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-05-21 | 2025-05-21 | 9,926 | $29.00 | $287.9K | 187,258 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-05-09 | 2025-05-12 | 5,737 | $29.13 | $167.1K | 110,143 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-05-09 | 2025-05-12 | 4,811 | $29.13 | $140.1K | 105,332 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise deriv | 2025-03-11 | 2025-03-12 | 15,910 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise deriv | 2025-03-11 | 2025-03-12 | 19,092 | — | $0 | 0 | SEC↗ |
| Davis John E | Chief Commercial Officer | M Exercise | 2025-03-11 | 2025-03-12 | 15,910 | $21.55 | $342.9K | 223,878 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-03-11 | 2025-03-12 | 15,100 | $23.61 | $356.5K | 208,778 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-03-11 | 2025-03-12 | 18,020 | $23.61 | $425.5K | 197,184 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | M Exercise | 2025-03-11 | 2025-03-12 | 19,092 | $21.55 | $411.4K | 215,204 | SEC↗ |
| Mackin James P | President & CEO | M Exercise deriv | 2025-03-06 | 2025-03-10 | 75,615 | — | $0 | 0 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-03-06 | 2025-03-10 | 2,124 | $24.80 | $52.7K | 196,112 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | A Award | 2025-03-06 | 2025-03-10 | 25,493 | — | $0 | 198,236 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-03-06 | 2025-03-10 | 1,603 | $24.80 | $39.8K | 115,880 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | A Award | 2025-03-06 | 2025-03-10 | 19,240 | — | $0 | 117,483 | SEC↗ |
| Davis John E | Chief Commercial Officer | A Award | 2025-03-06 | 2025-03-10 | 25,654 | — | $0 | 210,586 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-03-06 | 2025-03-10 | 2,618 | $24.80 | $64.9K | 207,968 | SEC↗ |
| Berry Lance A | Executive VP, CFO | A Award | 2025-03-06 | 2025-03-10 | 48,100 | — | $0 | 158,340 | SEC↗ |
| Berry Lance A | Executive VP, CFO | S Sale | 2025-03-06 | 2025-03-10 | 4,909 | $24.80 | $121.7K | 153,431 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2025-03-06 | 2025-03-10 | 10,261 | — | $0 | 147,699 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-03-06 | 2025-03-10 | 1,048 | $24.80 | $26.0K | 146,651 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-03-06 | 2025-03-10 | 17,739 | $24.80 | $439.9K | 860,368 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2025-03-06 | 2025-03-10 | 115,701 | — | $0 | 878,107 | SEC↗ |
| Mackin James P | President & CEO | M Exercise | 2025-03-06 | 2025-03-10 | 75,615 | $21.55 | $1.63M | 935,983 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-03-06 | 2025-03-10 | 70,700 | $24.76 | $1.75M | 865,283 | SEC↗ |
| SEMEDO ANTHONY B. | Director | P Buy | 2025-03-05 | 2025-03-05 | 1,500 | $25.33 | $38.0K | 35,659 | SEC↗ |
| SEMEDO ANTHONY B. | Director | P Buy | 2025-03-05 | 2025-03-05 | 600 | $25.25 | $15.2K | 600 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-03-05 | 2025-03-06 | 472 | $25.29 | $11.9K | 172,743 | SEC↗ |
| Berry Lance A | Executive VP, CFO | A Award | 2025-02-28 | 2025-03-04 | 34,435 | — | $0 | 110,240 | SEC↗ |
| Davis John E | Chief Commercial Officer | A Award | 2025-02-28 | 2025-03-04 | 24,301 | — | $0 | 184,932 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | A Award | 2025-02-28 | 2025-03-04 | 23,416 | — | $0 | 173,215 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2025-02-28 | 2025-03-04 | 6,297 | — | $0 | 137,438 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2025-02-28 | 2025-03-04 | 98,524 | — | $0 | 762,406 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | A Award | 2025-02-28 | 2025-03-04 | 18,398 | — | $0 | 98,243 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-02-24 | 2025-02-26 | 1,246 | $27.31 | $34.0K | 79,845 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-02-24 | 2025-02-26 | 672 | $27.31 | $18.4K | 81,091 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-02-24 | 2025-02-26 | 470 | $27.31 | $12.8K | 81,763 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2025-02-24 | 2025-02-26 | 2,299 | $27.31 | $62.8K | 82,233 | SEC↗ |
| Berry Lance A | Executive VP, CFO | S Sale | 2025-02-24 | 2025-02-26 | 3,259 | $27.31 | $89.0K | 75,805 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-02-24 | 2025-02-26 | 591 | $27.31 | $16.1K | 163,651 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-02-24 | 2025-02-26 | 2,846 | $27.31 | $77.7K | 164,242 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-02-24 | 2025-02-26 | 985 | $27.31 | $26.9K | 162,666 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2025-02-24 | 2025-02-26 | 2,035 | $27.31 | $55.6K | 160,631 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-02-24 | 2025-02-26 | 1,650 | $27.31 | $45.1K | 149,799 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-02-24 | 2025-02-26 | 810 | $27.31 | $22.1K | 151,449 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-02-24 | 2025-02-26 | 490 | $27.31 | $13.4K | 152,259 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2025-02-24 | 2025-02-26 | 2,385 | $27.31 | $65.1K | 152,749 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-02-24 | 2025-02-26 | 6,812 | $27.31 | $186.0K | 668,778 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-02-24 | 2025-02-26 | 16,664 | $27.31 | $455.1K | 689,374 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-02-24 | 2025-02-26 | 13,784 | $27.31 | $376.4K | 675,590 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2025-02-24 | 2025-02-26 | 4,896 | $27.31 | $133.7K | 663,882 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-02-24 | 2025-02-26 | 814 | $27.31 | $22.2K | 131,944 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-02-24 | 2025-02-26 | 1,706 | $27.31 | $46.6K | 132,758 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-02-24 | 2025-02-26 | 485 | $27.31 | $13.2K | 131,141 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2025-02-24 | 2025-02-26 | 318 | $27.31 | $8.7K | 131,626 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | G Gift | 2024-12-12 | 2024-12-13 | 1,100 | — | $0 | 134,464 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-12-11 | 2024-12-12 | 4,035 | $30.00 | $121.0K | 153,862 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-12-11 | 2024-12-12 | 4,035 | $30.25 | $122.1K | 157,897 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2024-12-06 | 2024-12-09 | 4,329 | $29.66 | $128.4K | 135,660 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2024-12-06 | 2024-12-10 | 4,425 | $29.05 | $128.5K | 135,564 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-12-04 | 2024-12-04 | 7,618 | $30.00 | $228.5K | 33,503 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise deriv | 2024-10-01 | 2024-10-02 | 12,430 | — | $0 | 0 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2024-10-01 | 2024-10-02 | 12,430 | $26.18 | $325.4K | 139,989 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | M Exercise | 2024-10-01 | 2024-10-02 | 12,430 | $21.55 | $267.9K | 152,419 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-08-26 | 2024-08-27 | 3,167 | $26.55 | $84.1K | 161,932 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-08-16 | 2024-08-19 | 6,858 | $25.31 | $173.6K | 36,678 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-08-16 | 2024-08-19 | 2,562 | $25.31 | $64.8K | 34,116 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-08-15 | 2024-08-16 | 2,383 | $25.76 | $61.4K | 165,099 | SEC↗ |
| SEMEDO ANTHONY B. | Director | S Sale | 2024-08-13 | 2024-08-15 | 9,709 | $24.99 | $242.6K | 34,159 | SEC↗ |
| Hoff Elizabeth A | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 25,064 | SEC↗ |
| SEMEDO ANTHONY B. | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 43,868 | SEC↗ |
| Borgstrom Marna P | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 42,763 | SEC↗ |
| Burbank Jeffrey H | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 47,471 | SEC↗ |
| Bullock James | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 62,322 | SEC↗ |
| Salveson Jon W | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 123,515 | SEC↗ |
| BEVEVINO DANIEL J | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 143,736 | SEC↗ |
| ACKERMAN THOMAS F | Director | A Award | 2024-05-30 | 2024-06-03 | 6,289 | — | $0 | 143,571 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-05-10 | 2024-05-13 | 1,250 | $23.42 | $29.3K | 167,482 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-05-09 | 2024-05-10 | 979 | $23.79 | $23.3K | 168,732 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2024-03-20 | 2024-03-21 | 2,183 | $20.39 | $44.5K | 83,296 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-03-15 | 2024-03-18 | 1,462 | $20.00 | $29.2K | 41,121 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-03-14 | 2024-03-15 | 3,994 | $20.00 | $79.9K | 42,583 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-03-12 | 2024-03-14 | 5,000 | $19.94 | $99.7K | 43,536 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2024-03-05 | 2024-03-07 | 1,152 | $18.72 | $21.6K | 139,957 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2024-03-05 | 2024-03-07 | 1,506 | $18.72 | $28.2K | 85,438 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-03-05 | 2024-03-07 | 1,160 | $18.72 | $21.7K | 46,541 | SEC↗ |
| Maney Rochelle L. | VP, Quality | S Sale | 2024-03-05 | 2024-03-07 | 1,157 | $18.72 | $21.7K | 46,536 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-03-05 | 2024-03-07 | 1,157 | $18.72 | $21.7K | 48,503 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2024-03-05 | 2024-03-07 | 2,022 | $18.72 | $37.9K | 165,637 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-03-05 | 2024-03-07 | 2,380 | $18.72 | $44.6K | 169,669 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2024-03-05 | 2024-03-07 | 13,996 | $18.72 | $262.0K | 705,562 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2024-03-05 | 2024-03-14 | 13,996 | $18.72 | $262.0K | 706,038 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2024-03-05 | 2024-03-14 | 2,022 | $18.72 | $37.9K | 165,690 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-03-05 | 2024-03-14 | 1,157 | $18.72 | $21.7K | 48,536 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-03-05 | 2024-03-14 | 1,160 | $18.72 | $21.7K | 46,577 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-03-05 | 2024-03-14 | 2,380 | $18.72 | $44.6K | 169,711 | SEC↗ |
| Maney Rochelle L. | VP, Quality | S Sale | 2024-03-05 | 2024-03-14 | 1,157 | $18.72 | $21.7K | 46,569 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2024-03-05 | 2024-03-14 | 1,152 | $18.72 | $21.6K | 139,989 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2024-03-01 | 2024-03-07 | 3,578 | — | $0 | 141,109 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | A Award | 2024-03-01 | 2024-03-07 | 5,724 | — | $0 | 86,944 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | A Award | 2024-03-01 | 2024-03-07 | 3,578 | — | $0 | 47,701 | SEC↗ |
| Maney Rochelle L. | VP, Quality | A Award | 2024-03-01 | 2024-03-07 | 3,578 | — | $0 | 47,693 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award | 2024-03-01 | 2024-03-07 | 3,578 | — | $0 | 49,660 | SEC↗ |
| Davis John E | Chief Commercial Officer | A Award | 2024-03-01 | 2024-03-07 | 5,724 | — | $0 | 167,659 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | A Award | 2024-03-01 | 2024-03-07 | 5,724 | — | $0 | 172,049 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2024-03-01 | 2024-03-07 | 28,618 | — | $0 | 719,558 | SEC↗ |
| Mackin James P | President & CEO | A Award | 2024-03-01 | 2024-03-14 | 28,618 | — | $0 | 720,034 | SEC↗ |
| Davis John E | Chief Commercial Officer | A Award | 2024-03-01 | 2024-03-14 | 5,724 | — | $0 | 167,712 | SEC↗ |
| Getz Matthew A | VP, Human Resources | A Award | 2024-03-01 | 2024-03-14 | 3,578 | — | $0 | 49,693 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | A Award | 2024-03-01 | 2024-03-14 | 3,578 | — | $0 | 47,737 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | A Award | 2024-03-01 | 2024-03-14 | 5,724 | — | $0 | 172,091 | SEC↗ |
| Maney Rochelle L. | VP, Quality | A Award | 2024-03-01 | 2024-03-14 | 3,578 | — | $0 | 47,726 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | A Award | 2024-03-01 | 2024-03-14 | 5,724 | — | $0 | 86,985 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2024-03-01 | 2024-03-14 | 1,506 | $18.72 | $28.2K | 85,479 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | A Award | 2024-03-01 | 2024-03-14 | 3,578 | — | $0 | 141,141 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2024-02-27 | 2024-02-29 | 465 | $19.83 | $9.2K | 81,220 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-02-27 | 2024-02-29 | 421 | $19.83 | $8.3K | 44,123 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-02-27 | 2024-02-29 | 325 | $19.83 | $6.4K | 46,082 | SEC↗ |
| Maney Rochelle L. | VP, Quality | S Sale | 2024-02-27 | 2024-02-29 | 370 | $19.83 | $7.3K | 44,115 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2024-02-27 | 2024-02-29 | 584 | $19.83 | $11.6K | 161,935 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-02-27 | 2024-02-29 | 485 | $19.83 | $9.6K | 166,325 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2024-02-27 | 2024-02-29 | 4,837 | $19.83 | $95.9K | 690,940 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2024-02-27 | 2024-02-29 | 325 | $19.83 | $6.4K | 137,531 | SEC↗ |
| Tyrs Florian | VP, Global Operations | S Sale | 2024-02-27 | 2024-02-29 | 339 | $19.83 | $6.7K | 21,558 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2024-02-27 | 2024-03-14 | 4,837 | $19.83 | $95.9K | 691,416 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-02-27 | 2024-03-14 | 325 | $19.83 | $6.4K | 46,115 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-02-27 | 2024-03-14 | 485 | $19.83 | $9.6K | 166,367 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2024-02-27 | 2024-03-14 | 584 | $19.83 | $11.6K | 161,988 | SEC↗ |
| Horton Amy | VP, Chief Accounting Officer | S Sale | 2024-02-27 | 2024-03-14 | 325 | $19.83 | $6.4K | 137,563 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-02-27 | 2024-03-14 | 421 | $19.83 | $8.3K | 44,159 | SEC↗ |
| Maney Rochelle L. | VP, Quality | S Sale | 2024-02-27 | 2024-03-14 | 370 | $19.83 | $7.3K | 44,148 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2024-02-27 | 2024-03-14 | 465 | $19.83 | $9.2K | 81,261 | SEC↗ |
| Tyrs Florian | VP, Global Operations | S Sale | 2024-02-26 | 2024-02-28 | 893 | $20.27 | $18.1K | 21,897 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2024-02-26 | 2024-02-28 | 1,600 | $20.27 | $32.4K | 72,489 | SEC↗ |
| Stanton Marshall S. | SVP, Clinical & MD Affair | S Sale | 2024-02-26 | 2024-02-28 | 1,448 | $20.27 | $29.4K | 81,685 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-02-26 | 2024-02-28 | 1,185 | $20.27 | $24.0K | 38,848 | SEC↗ |
| GREEN ANDREW M | VP Regulatory | S Sale | 2024-02-26 | 2024-02-28 | 1,218 | $20.27 | $24.7K | 44,544 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-02-26 | 2024-02-28 | 1,185 | $20.27 | $24.0K | 40,123 | SEC↗ |
| Getz Matthew A | VP, Human Resources | S Sale | 2024-02-26 | 2024-02-28 | 1,128 | $20.27 | $22.9K | 46,407 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2024-02-26 | 2024-02-28 | 1,610 | $20.27 | $32.6K | 151,687 | SEC↗ |
| Davis John E | Chief Commercial Officer | S Sale | 2024-02-26 | 2024-02-28 | 1,904 | $20.27 | $38.6K | 162,519 | SEC↗ |
| Maney Rochelle L. | VP, Quality | S Sale | 2024-02-26 | 2024-02-28 | 1,130 | $20.27 | $22.9K | 44,485 | SEC↗ |
| Maney Rochelle L. | VP, Quality | S Sale | 2024-02-26 | 2024-02-28 | 1,185 | $20.27 | $24.0K | 39,197 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-02-26 | 2024-02-28 | 1,566 | $20.27 | $31.7K | 166,810 | SEC↗ |
| Holloway Jean F | SVP, General Counsel | S Sale | 2024-02-26 | 2024-02-28 | 1,314 | $20.27 | $26.6K | 155,540 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2024-02-26 | 2024-02-28 | 13,168 | $20.27 | $266.9K | 695,777 | SEC↗ |
| Mackin James P | President & CEO | S Sale | 2024-02-26 | 2024-02-28 | 18,144 | $20.27 | $367.8K | 650,297 | SEC↗ |